Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000173522 | SCV000224643 | benign | not specified | 2015-03-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000946604 | SCV001092748 | benign | not provided | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000946604 | SCV001804967 | likely benign | not provided | 2021-02-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002336419 | SCV002644356 | benign | Cardiovascular phenotype | 2019-07-16 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000173522 | SCV004029671 | likely benign | not specified | 2023-07-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000173522 | SCV003839903 | likely benign | not specified | 2022-11-28 | no assertion criteria provided | clinical testing |